Search - tctmd.com

Displaying 201 - 220 of 310

Sort: Relevancy | Date

Presentation TCT 2014

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Miha Cercek

September 16, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Marko Noc

September 16, 2014

Presentation TCT 2014

Case #1: CTO in the Setting of ACS

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Aggeliki-Despoina F. Mavrogianni

September 16, 2014

Presentation TCT 2014

Transcatheter-Based Homologous Off-the-Shelf Tissue Engineered Heart Valves with Self-Repair Capacity: Long-term Functionality and Rapid In Vivo Remodeling in Sheep

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Maximilian Y Emmert

September 15, 2014

Presentation TCT 2014

The Emboline Aortic Embolic Protection Technology

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Scott Russell

September 15, 2014

Presentation TCT 2014

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Albert Hsiao

September 15, 2014

Presentation TCT 2014

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Carl Schultz

September 15, 2014

Presentation TCT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

September 15, 2014

Presentation TCT 2014

Thubikar Valve Technology Review

Presenter: Susheel Kodali

September 15, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

Presentation TCT 2014

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Susheel Kodali

September 14, 2014

Presentation TCT 2014

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Presenter: Kishore J. Harjai, Susheel Kodali

September 14, 2014

Presentation TCT 2014

Next-Generation Valves for TAVR

Presenter: Sarah Clarke, Marian C. Hawkey, Thomas H. Maloney, Susheel Kodali

September 14, 2014

Presentation TCT 2014

An Algorithm for Patient Monitoring Postprocedure

Presenter: Susheel Kodali, Sreenivas Arramraju Kumar, Manish A. Parikh

September 13, 2014

Presentation TCT 2014

Case #10: Acute MI with Massive Gastrointestinal Bleeding

Presenter: Susheel Kodali, Sreenivas Arramraju Kumar, Bhupinder Singh

September 13, 2014

News Daily News

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Yael L. Maxwell

September 02, 2014

News Daily News

Valorar la Calcificación de la Válvula Aórtica Podría Ayudar a Predecir la Fuga Paravalvular post-TAVR

Yael L. Maxwell

September 02, 2014

News Daily News

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Yael L. Maxwell

September 02, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

Advertisement

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

How Would I Treat This Patient?

Case #1: CTO in the Setting of ACS

Transcatheter-Based Homologous Off-the-Shelf Tissue Engineered Heart Valves with Self-Repair Capacity: Long-term Functionality and Rapid In Vivo Remodeling in Sheep

The Emboline Aortic Embolic Protection Technology

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Thubikar Valve Technology Review

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Next-Generation Valves for TAVR

An Algorithm for Patient Monitoring Postprocedure

Case #10: Acute MI with Massive Gastrointestinal Bleeding

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Valorar la Calcificación de la Válvula Aórtica Podría Ayudar a Predecir la Fuga Paravalvular post-TAVR

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content